Muhammad Ajmal Khan

8PUBLICATIONS
43CO-AUTHORS
Predictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Immunogenetics (incl. genetic immunology)Cancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|May 22, 2026
Twist1 overexpression models an aggressive subtype of pancreatic ductal adenocarcinoma in vivo.

|Mar 16, 2026
TNIK Overexpression Is Sufficient for Chemoradiation Resistance in Limited-Stage Small Cell Lung Cancer.

Dipanwita Dutta Chowdhury, Eddie L Imada, Nick Connis

|Jun 10, 2024
TNIK Inhibition Sensitizes TNIK-Overexpressing Lung Squamous Cell Carcinoma to Radiotherapy.

Triet Nguyen, Francesca A Carrieri, Nick Connis

|Apr 26, 2024
TNIK Inhibition Sensitizes TNIK-Overexpressing Lung Squamous Cell Carcinoma to Radiotherapy.

Triet Nguyen, Francesca A Carrieri, Nick Connis

|Jan 21, 2023
Recent Advances in Genomics-Based Approaches for the Development of Intracellular Bacterial Pathogen Vaccines.

Muhammad Ajmal Khan, Aftab Amin, Awais Farid

|Jan 04, 2023
An essential Noc3p dimerization cycle mediates ORC double-hexamer formation in replication licensing.

Aftab Amin, Rentian Wu, Muhammad Ajmal Khan

Pageof 2

Frequent Collaborators

4 joint publications

Audrey Lafargue

4 joint publications

Jinhee Chang

4 joint publications

Phuoc T Tran

3 joint publications

Triet Nguyen